Monika Hansson

Publications
Public outreach and news

Articles

Article: ARTHRITIS & RHEUMATOLOGY. 2025;77(9):1179-1193
Recognition of Glycine Versus Nonglycine Citrulline Motifs Dictating the HLA Class II Association of Anticitrullinated Protein Antibodies: Insights From Autoantibody Profiling of 6,900 Scandinavian Patients With Rheumatoid Arthritis
Alm LM; Westerlind H; Gehring I; Hansson M; Ghasemzadeh N; Rojas-Restrepo J; Saevarsdottir S; Sexton J; Lillegraven S; Haavardsholm E; Glintborg B; Hammer HB; Kvien TK; Hetland ML; Padyukov L; Askling J; Gronwall C
Article: CLINICAL IMMUNOLOGY. 2025;275:110476
Diffuse large B cell lymphoma in rheumatoid arthritis patients is associated with elevated B-cell driving factors including CXCL13
Euler N; Hellbacher E; af Klint E; Hansson M; Larsson A; Enblad G; Malmstrom V; Baecklund E; Gronwall C
Article: ACR OPEN RHEUMATOLOGY. 2025;7(1):e11767
Revisiting the Link Between HLA-DRB1 Alleles and Autoantibodies in Rheumatoid Arthritis: Association of non-Shared Epitope Alleles*09 and*15 With High Levels of Anti-Citrullinated Peptide/Protein Antibodies
Lagutkin D; Panaifo L; Nurul-Aain A-F; Israelsson L; Hansson M; Lundberg K; Alfredsson L; Askling J; Klareskog L; Too C-L; Padyukov L
Article: RHEUMATOLOGY. 2024;63(11):3106-3114
Identification of circulating autoantibodies to non-modified proteins associated with ACPA status in early rheumatoid arthritis
Lourido L; Joshua V; Hansson M; Sjoberg R; Pin E; Ruiz-Romero C; Nilsson P; Alfredsson L; Klareskog L; Blanco FJ
Article: RHEUMATOLOGY. 2024;63(11):3164-3171
Identification of early risk factors for anti-citrullinated-protein-antibody positive rheumatoid arthritis-a prospective cohort study
Circiumaru A; Kisten Y; Hansson M; Mathsson-Alm L; Joshua V; Waehaemaa H; Loberg Haarhaus M; Lindqvist J; Padyukov L; Catrina S-B; Fei G; Vivar N; Rezaei H; af Klint E; Antovic A; Rethi B; Catrina AI; Hensvold A
Article: MICROBIOLOGY SPECTRUM. 2024;12(4):e0298123-e02923
The serological immunogenicity of the third and fourth doses of COVID-19 vaccine in patients with inflammatory rheumatic diseases on different biologic or targeted DMARDs: a Swedish nationwide study (COVID-19-REUMA)
Frodlund M; Nived P; Chatzidionysiou K; Soedergren A; Klingberg E; Hansson M; Ohlsson S; Pin E; Bengtsson A; Klareskog L; Kapetanovic M
Article: ANNALS OF THE RHEUMATIC DISEASES. 2024;83(3):277-287
In early rheumatoid arthritis, anticitrullinated peptide antibodies associate with low number of affected joints and rheumatoid factor associates with systemic inflammation
Pertsinidou E; Saevarsdottir S; Manivel VA; Klareskog L; Alfredsson L; Mathsson-Alm L; Hansson M; Cornillet M; Serre G; Holmdahl R; Skriner K; Jakobsson P-J; Westerlind H; Askling J; Roennelid J
Article: FRONTIERS IN PHYSIOLOGY. 2024;15:1342351
Gastrointestinal symptoms in patients with postural orthostatic tachycardia syndrome in relation to hemodynamic findings and immunological factors
Tufvesson H; Hamrefors V; Fedorowski A; Hansson M; Ohlsson B
Article: ARTHRITIS & RHEUMATOLOGY. 2023;75(11):1910-1922
Rheumatoid Arthritis-Specific Autoimmunity in the Lung Before and at the Onset of Disease
Joshua V; Loberg Haarhaus M; Hensvold A; Wahamaa H; Gerstner C; Hansson M; Israelsson L; Stalesen R; Skoeld M; Grunewald J; Klareskog L; Groenwall C; Rethi B; Catrina A; Malmstrom V
Article: JOURNAL OF BIOLOGICAL CHEMISTRY. 2023;299(11):105320
Autoreactive B cells against malondialdehyde-induced protein cross-links are present in the joint, lung, and bone marrow of rheumatoid arthritis patients
Sahlstrom P; Joshua V; Valkovskaia V; Biese C; Stalesen R; Israelsson L; Vegvari A; Scheel-Toellner D; Klareskog L; Hansson M; Hensvold A; Malmstrom V; Gronwall C
Article: RESPIROLOGY. 2023;28(10):925-933
Presence of anti-modified protein antibodies in idiopathic pulmonary fibrosis
Kalafatis D; Joshua V; Hansson M; Mathsson-Alm L; Hensvold A; Skold M
Article: RHEUMATOLOGY. 2023;62(6):2106-2112
The association between autoantibodies and risk for venous thromboembolic events among patients with rheumatoid arthritis
Westerlind H; Kastbom A; Ronnelid J; Hansson M; Alfredsson L; Mathsson-Alm L; Serre G; Cornillet M; Holmdahl R; Skriner K; Bang H; Klareskog L; Saevarsdottir S; Lundberg K; Gronwall C; Askling J
Article: VACCINE. 2023;41(20):3247-3257
The impact of immunomodulating treatment on the immunogenicity of COVID-19 vaccines in patients with immune-mediated inflammatory rheumatic diseases compared to healthy controls. A Swedish nationwide study (COVID19-REUMA)
Frodlund M; Nived P; Chatzidionysiou A; Sodergren A; Klingberg E; Bengtsson A; Hansson M; Olsson S; Pin E; Klareskog L; Kapetanovic MC
Article: JOURNAL OF AUTOIMMUNITY. 2023;136:103022
The human bone marrow plasma cell compartment in rheumatoid arthritis-Clonal relationships and anti-citrulline autoantibody producing cells
Hensvold A; Horuluoglu B; Sahlstrom P; Thyagarajan R; Boada JSD; Hansson M; Mathsson-Alm L; Gerstner C; Sippl N; Israelsson L; Wedin R; Steen J; Klareskog L; Rethi B; Catrina AI; Diaz-Gallo L-M; Malmstrom V; Gronwall C
Article: BIOMOLECULES. 2023;13(4):630
Anti-Citrullinated Protein Antibody Reactivity towards Neutrophil-Derived Antigens: Clonal Diversity and Inter-Individual Variation
Circiumaru A; Afonso MG; Wahamaa H; Krishnamurthy A; Hansson M; Mathsson-Alm L; Keszei M; Stalesen R; Ottosson L; de Vries C; Shelef MA; Malmstrom V; Klareskog L; Catrina AI; Gronwall C; Hensvold A; Rethi B
Article: RHEUMATOLOGY. 2022;61(12):4985-4990
Anti-citrullinated protein antibody specificities and pulmonary fibrosis in relation to genetic loci in early rheumatoid arthritis
Brink M; Ljung L; Hansson M; Ronnelid J; Holmdahl R; Skriner K; Serre G; Klareskog L; Rantapaa-Dahlqvist S
Article: FRONTIERS IN IMMUNOLOGY. 2022;13:804822
Antibodies to a Citrullinated Porphyromonas gingivalis Epitope Are Increased in Early Rheumatoid Arthritis, and Can Be Produced by Gingival Tissue B Cells: Implications for a Bacterial Origin in RA Etiology
Sherina N; de Vries C; Kharlamova N; Sippl N; Jiang X; Brynedal B; Kindstedt E; Hansson M; Mathsson-Alm L; Israelsson L; Stalesen R; Saevarsdottir S; Holmdahl R; Hensvold A; Johannsen G; Eriksson K; Sallusto F; Catrina AI; Roennelid J; Groenwall C; Yucel-Lindberg T; Alfredsson L; Klareskog L; Piccoli L; Malmstroem V; Amara K; Lundberg K
Article: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2021;39(4):879-882
Rheumatoid arthritis autoantibodies and their association with age and sex
Pertsinidou E; Manivel VA; Westerlind H; Klareskog L; Alfredsson L; Mathsson-Alm L; Hansson M; Saevatsdottir S; Askling J; Ronnelid J
Article: FRONTIERS IN IMMUNOLOGY. 2021;12:627986
A Comprehensive Evaluation of the Relationship Between Different IgG and IgA Anti-Modified Protein Autoantibodies in Rheumatoid Arthritis
Gronwall C; Liljefors L; Bang H; Hensvold AH; Hansson M; Mathsson-Alm L; Israelsson L; Joshua V; Svard A; Stalesen R; Titcombe PJ; Steen J; Piccoli L; Sherina N; Clavel C; Svenungsson E; Gunnarsson I; Saevarsdottir S; Kastbom A; Serre G; Alfredsson L; Malmstrom V; Ronnelid J; Catrina AI; Lundberg K; Klareskog L
Article: ARTHRITIS & RHEUMATOLOGY. 2020;72(10):1643-1657
Different Hierarchies of Anti-Modified Protein Autoantibody Reactivities in Rheumatoid Arthritis
Sahlstroem P; Hansson M; Steen J; Amara K; Titcombe PJ; Forsstrom B; Stalesen R; Israelsson L; Piccoli L; Lundberg K; Klareskog L; Mueller DL; Catrina AI; Skriner K; Malmstrom V; Gronwall C
Article: ARTHRITIS & RHEUMATOLOGY. 2020;72(10):1658-1667
Anti-Citrullinated Protein Antibody Specificities, Rheumatoid Factor Isotypes, and Incident Cardiovascular Events in Patients With Rheumatoid Arthritis
Westerlind H; Ronnelid J; Hansson M; Alfredsson L; Mathsson-Alm L; Serre G; Cornillet M; Holmdahl R; Jakobsson P-J; Skriner K; Klareskog L; Saevarsdottir S; Askling J
Article: RMD OPEN. 2020;6(2):e001278
Association between number and type of different ACPA fine specificities with lung abnormalities in early, untreated rheumatoid arthritis
Joshua V; Hensvold AH; Reynisdottir G; Hansson M; Cornillet M; Nogueira L; Serre G; Nyren S; Karimi R; Eklund A; Skold M; Grunewald J; Chatzidionysiou K; Catrina A
Article: ARTHRITIS RESEARCH & THERAPY. 2020;22(1):170
Presence of autoantibodies in "seronegative" rheumatoid arthritis associates with classical risk factors and high disease activity
Reed E; Hedstrom AK; Hansson M; Mathsson-Alm L; Brynedal B; Saevarsdottir S; Cornillet M; Jakobsson P-J; Holmdahl R; Skriner K; Serre G; Alfredsson L; Ronnelid J; Lundberg K
Article: SCIENTIFIC REPORTS. 2019;9(1):19995
Rheumatoid arthritis patients display B-cell dysregulation already in the naive repertoire consistent with defects in B-cell tolerance
Wang Y; Lloyd KA; Melas I; Zhou D; Thyagarajan R; Lindqvist J; Hansson M; Svard A; Mathsson-Alm L; Kastbom A; Lundberg K; Klareskog L; Catrina AI; Rapecki S; Malmstrom V; Gronwall C
Article: AMERICAN JOURNAL OF HUMAN GENETICS. 2019;105(3):616-624
Distinct HLA Associations with Rheumatoid Arthritis Subsets Defined by Serological Subphenotype
Terao C; Brynedal B; Chen Z; Jiang X; Westerlind H; Hansson M; Jakobsson P-J; Lundberg K; Skriner K; Serre G; Ronnelid J; Mathsson-Alm L; Brink M; Dahlqvist SR; Padyukov L; Gregersen PK; Barton A; Alfredsson L; Klareskog L; Raychaudhuri S
Article: ARTHRITIS & RHEUMATOLOGY. 2019;71(3):340-350
Generation and Characterization of Anti-Citrullinated Protein Antibody-Producing B Cell Clones From Rheumatoid Arthritis Patients
Germar K; Fehres CM; Scherer HU; van Uden N; Pollastro S; Yeremenko N; Hansson M; Kerkman PF; van der Voort EIH; Reed E; Maassen H; Kwakkenbos MJ; Bakker AQ; Klareskog L; Malmstrom V; de Vries N; Toes REM; Lundberg K; Spits H; Baeten DL
Article: ANNALS OF THE RHEUMATIC DISEASES. 2019;78(2):179-185
Effects of B-cell directed therapy on the preclinical stage of rheumatoid arthritis: the PRAIRI study
Gerlag DM; Safy M; Maijer KI; Tang MW; Tas SW; Starmans-Kool MJF; van Tubergen A; Janssen M; de Hair M; Hansson M; de Vries N; Zwinderman AH; Tak PP
Article: ARTHRITIS & RHEUMATOLOGY. 2019;71(2):196-209
Recognition of Amino Acid Motifs, Rather Than Specific Proteins, by Human Plasma Cell-Derived Monoclonal Antibodies to Posttranslationally Modified Proteins in Rheumatoid Arthritis
Steen J; Forsstroem B; Sahlstroem P; Odowd V; Israelsson L; Krishnamurthy A; Badreh S; Alm LM; Compson J; Ramskold D; Ndlovu W; Rapecki S; Hansson M; Titcombe PJ; Bang H; Mueller DL; Catrina AI; Gronwall C; Skriner K; Nilsson P; Lightwood D; Klareskog L; Malmstrom V
Article: THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE. 2019;11:1759720X19883152
A cross-sectional investigation into the association between Porphyromonas gingivalis and autoantibodies to citrullinated proteins in a German population
Oluwagbemigun K; Yucel-Lindberg T; Dietrich T; Tour G; Sherina N; Hansson M; Bergmann M; Lundberg K; Boeing H
Article: RMD OPEN. 2019;5(2):e000946
Antibodies against citrullinated peptides are associated with clinical and radiological outcomes in patients with early rheumatoid arthritis: a prospective longitudinal inception cohort study
Boman A; Brink M; Lundquist A; Hansson M; Mathsson-Alm L; Ronnelid J; Berglin E; Holmdahl R; Skriner K; Serre G; Klareskog L; Rantapaa-Dahlqvist S
Article: ARTHRITIS & RHEUMATOLOGY. 2018;70(12):1933-1945
Pathogenic Citrulline-Multispecific B Cell Receptor Clades in Rheumatoid Arthritis
Titcombe PJ; Wigerblad G; Sippl N; Zhang N; Shmagel AK; Sahlstrom P; Zhang Y; Barsness LO; Ghodke-Puranik Y; Baharpoor A; Hansson M; Israelsson L; Skriner K; Niewold TB; Klareskog L; Svensson CI; Amara K; Malmstrom V; Mueller DL
Article: ANNALS OF THE RHEUMATIC DISEASES. 2018;77(9):1345-1353
Number of individual ACPA reactivities in synovial fluid immune complexes, but not serum anti-CCP2 levels, associate with inflammation and joint destruction in rheumatoid arthritis
Sohrabian A; Mathsson-Alm L; Hansson M; Knight A; Lysholm J; Cornillet M; Skriner K; Serre G; Larsson A; Weitoft T; Ronnelid J
Article: ARTHRITIS RESEARCH & THERAPY. 2018;20(1):146
The role of anti-citrullinated protein antibody reactivities in an inception cohort of patients with rheumatoid arthritis receiving treat-to-target therapy
Jonsson MK; Hensvold AH; Hansson M; Aga A-B; Sexton J; Mathsson-Alm L; Cornillet M; Serre G; Lillegraven S; Fevang B-TS; Catrina AI; Haavardsholm EA
Article: ANNALS OF THE RHEUMATIC DISEASES. 2018;77(2):203-211
Anticitrullinated protein/peptide antibody multiplexing defines an extended group of ACPA-positive rheumatoid arthritis patients with distinct genetic and environmental determinants
Ronnelid J; Hansson M; Mathsson-Alm L; Cornillet M; Reed E; Jakobsson P-J; Alfredsson L; Holmdahl R; Skriner K; Serre G; Lundberg K; Klareskog L
Article: ARTHRITIS RESEARCH & THERAPY. 2017;19(1):219
Low levels of antibodies against common viruses associate with anti-citrullinated protein antibody-positive rheumatoid arthritis; implications for disease aetiology
Sherina N; Hreggvidsdottir HS; Bengtsson C; Hansson M; Israelsson L; Alfredsson L; Lundberg K
Article: ARTHRITIS & RHEUMATOLOGY. 2017;69(1):58-69
Differences in the Spectrum of Anti-Citrullinated Protein Antibody Fine Specificities Between Malaysian and Swedish Patients With Rheumatoid Arthritis: Implications for Disease Pathogenesis
Too CL; Murad S; Hansson M; Alm LM; Dhaliwal JS; Holmdahl R; Jakobsson P-J; Alfredsson L; Klareskog L; Ronnelid J; Padyukov L
Article: ARTHRITIS RESEARCH & THERAPY. 2016;18(1):284
Antibody responses to de novo identified citrullinated fibrinogen peptides in rheumatoid arthritis and visualization of the corresponding B cells
Joshua V; Schobers L; Titcombe PJ; Israelsson L; Ronnelid J; Hansson M; Catrina AI; Pruijn GJM; Malmstrom V
Article: ARTHRITIS RESEARCH & THERAPY. 2016;18(1):96
Antibodies to carbamylated α-enolase epitopes in rheumatoid arthritis also bind citrullinated epitopes and are largely indistinct from anti-citrullinated protein antibodies
Reed E; Jiang X; Kharlamova N; Ytterberg AJ; Catrina AI; Israelsson L; Mathsson-Alm L; Hansson M; Alfredsson L; Ronnelid J; Lundberg K
Article: ARTHRITIS RESEARCH & THERAPY. 2016;18:43
Rheumatoid factor isotypes in relation to antibodies against citrullinated peptides and carbamylated proteins before the onset of rheumatoid arthritis
Brink M; Hansson M; Mathsson-Alm L; Wijayatunga P; Verheul MK; Trouw LA; Holmdahl R; Ronnelid J; Klareskog L; Rantapaa-Dahlqvist S
Article: ARTHRITIS RESEARCH & THERAPY. 2015;17(1):155
Targeting of anti-citrullinated protein/peptide antibodies in rheumatoid arthritis using peptides mimicking endogenously citrullinated fibrinogen antigens
Fernandes-Cerqueira C; Ossipova E; Gunasekera S; Hansson M; Mathsson L; Catrina AI; Sommarin Y; Klareskog L; Lundberg K; Ronnelid J; Goransson U; Jakobsson P-J
Article: ARTHRITIS RESEARCH & THERAPY. 2015;17(1):125
Associations of antibodies against citrullinated peptides with human leukocyte antigen-shared epitope and smoking prior to the development of rheumatoid arthritis
Kokkonen H; Brink M; Hansson M; Lassen E; Mathsson-Alm L; Holmdahl R; Ronnelid J; Klareskog L; Rantapaa-Dahlqvist S
Article: ANNALS OF THE RHEUMATIC DISEASES. 2015;74(2):375-380
Environmental and genetic factors in the development of anticitrullinated protein antibodies (ACPAs) and ACPA-positive rheumatoid arthritis: an epidemiological investigation in twins
Hensvold AH; Magnusson PKE; Joshua V; Hansson M; Israelsson L; Ferreira R; Jakobsson P-J; Holmdahl R; Hammarstrom L; Malmstrom V; Askling J; Klareskog L; Catrina AI
Article: ARTHRITIS & RHEUMATOLOGY. 2014;66(3):513-522
Features of the Synovium of Individuals at Risk of Developing Rheumatoid Arthritis
de Hair MJH; van de Sande MGH; Ramwadhdoebe TH; Hansson M; Landewe R; van der Leij C; Maas M; Serre G; van Schaardenburg D; Klareskog L; Gerlag DM; van Baarsen LGM; Tak PP
Article: ARTHRITIS & RHEUMATOLOGY. 2013;65(4):899-910
Multiplex Analyses of Antibodies Against Citrullinated Peptides in Individuals Prior to Development of Rheumatoid Arthritis
Brink M; Hansson M; Mathsson L; Jakobsson P-J; Holmdahl R; Hallmans G; Stenlund H; Ronnelid J; Klareskog L; Rantapaa-Dahlqvist S
Article: ARTHRITIS RESEARCH & THERAPY. 2012;14(5):R201
Validation of a multiplex chip-based assay for the detection of autoantibodies against citrullinated peptides
Hansson M; Mathsson L; Schlederer T; Israelsson L; Matsson P; Nogueira L; Jakobsson P-J; Lundberg K; Malmstrom V; Serre G; Holmdahl R; Nystrand M; Klareskog L; Ronnelid J
Article: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2011;38(3):531-539
Optimal specific radioactivity of anti-HER2 Affibody molecules enables discrimination between xenografts with high and low HER2 expression levels.
Tolmachev V; Wållberg H; Sandström M; Hansson M; Wennborg A; Orlova A
Article: JOURNAL OF NUCLEAR MEDICINE. 2010;51(7):1131-1138
Targeting of HER2-expressing tumors using 111In-ABY-025, a second-generation affibody molecule with a fundamentally reengineered scaffold.
Ahlgren S; Orlova A; Wållberg H; Hansson M; Sandström M; Lewsley R; Wennborg A; Abrahmsén L; Tolmachev V; Feldwisch J
Article: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2010;37(3):613-622
Imaging of EGFR expression in murine xenografts using site-specifically labelled anti-EGFR 111In-DOTA-Z EGFR:2377 Affibody molecule: aspect of the injected tracer amount.
Tolmachev V; Rosik D; Wållberg H; Sjöberg A; Sandström M; Hansson M; Wennborg A; Orlova A
Article: IMMUNOLOGY. 2005;114(3):428-437
Exposure to mercuric chloride during the induction phase and after the onset of collagen-induced arthritis enhances immune/autoimmune responses and exacerbates the disease in DBA/1 mice
Hansson M; Djerbi M; Rabbani H; Mellstedt H; Gharibdoost F; Hassan M; DePierre JW; Abedi-Valugerdi M
Article: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2004;59(5):469-477
Mercuric chloride induces a strong immune activation, but does not accelerate the development of dermal fibrosis in tight skin 1 mice
Hansson M; Abedi-Valugerdi M
Article: CLINICAL AND EXPERIMENTAL IMMUNOLOGY. 2003;131(3):405-414
Xenobiotic metal-induced autoimmunity:: mercury and silver differentially induce antinucleolar autoantibody production in susceptible H-2^s, H-2^q and H-2^f mice
Hansson M; Abedi-Valugerdi M
Article: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2001;54(1-2):190-197
Genetic control of resistance to mercury-induced immune/autoimmune activation
Abedi-Valugerdi M; Hansson M; Möller G
Show more

All other publications

Corrigendum: AMERICAN JOURNAL OF HUMAN GENETICS. 2019;105(4):880
Distinct HLA Associations with Rheumatoid Arthritis Subsets Defined by Serological Subphenotype (vol 105, pg 616, 2019)
Terao C; Brynedal B; Chen Z; Jiang X; Westerlind H; Hansson M; Jakobsson P-J; Lundberg K; Skriner K; Serre G; Ronnelid J; Mathsson-Alm L; Brink M; Dahlqvist SR; Padyukov L; Gregersen PK; Barton A; Alfredsson L; Klareskog L; Raychaudhuri S
Letter: ANNALS OF THE RHEUMATIC DISEASES. 2014;73(7):e46
The autoantibody repertoire in periodontitis: a role in the induction of autoimmunity to citrullinated proteins in rheumatoid arthritis? Antibodies against uncitrullinated peptides seem to occur prior to the antibodies to the corresponding citrullinated peptides
Brink M; Hansson M; Ronnelid J; Klareskog L; Dahlqvist SR
Letter: ARTHRITIS & RHEUMATOLOGY. 2014;66(6):1683-1684
Studies of preclinical rheumatoid arthritis synovial histology-a comparison of animal models: comment on the article by de Hair et al Reply
de Hair MJH; van de Sande MGH; Ramwadhdoebe TH; van der Leij C; Maas M; Hansson M; Klareskog L; Landewe R; Serre G; van Schaardenburg D; Gerlag DM; van Baarsen LGM; Tak PP

Articles

All other publications

News from KI

Events from KI